Halozyme Therapeutics, Inc. vs. Taysha Gene Therapies, Inc. Common Stock
HALO
Halozyme Therapeutics, Inc.
$122.50 +0.54%
VS TSHATaysha Gene Therapies, Inc. Common Stock
$4.11 +4.31%
Halozyme Therapeutics, Inc. and Taysha Gene Therapies, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| HALO | TSHA | |
|---|---|---|
| Market Cap | $13.83 billion | $1.28 billion |
HALO leads on 1 of 1 size & scale factors.
Risk & Sentiment
| HALO | TSHA | |
|---|---|---|
| Short Interest | 9.79% | 0.08% |
TSHA leads on 1 of 1 risk & sentiment factors.
Dig deeper: HALO overview, HALO financials, TSHA overview, TSHA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.